Literature DB >> 27354582

Premalignant Oral Lesion Cells Elicit Increased Cytokine Production and Activation of T-cells.

Sara D Johnson1, Corinne Levingston2, M Rita I Young3.   

Abstract

BACKGROUND: Head and neck squamous cell carcinomas (HNSCC) are known to evade the host immune response. How premalignant oral lesions modulate the immune response, however, has yet to be elucidated.
MATERIALS AND METHODS: A mouse model of oral carcinogenesis was used to determine how mediators from premalignant oral lesion cells vs. HNSCC cells impact on immune cytokine production and activation.
RESULTS: Media conditioned by premalignant lesion cells elicited an increased production of T cell-associated cytokines and proinflammatory mediators from cervical lymph node cells compared to media conditioned by HNSCC cells or media alone. In the presence of premalignant lesion cell-conditioned media, CD4(+) T cell expression of the IL-2 receptor CD25 and CD8(+) T cell expression of the activation marker CD69 was greater, compared to what was induced in HNSCC cell-conditioned media or media alone.
CONCLUSION: Premalignant lesion cells promote a proinflammatory environment and induce immune changes before HNSCC tumors are established. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  T cell activation; cytokines; head and neck cancer; premalignant oral lesions

Mesh:

Substances:

Year:  2016        PMID: 27354582      PMCID: PMC5032137     

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  38 in total

1.  The feasibility of monitoring NF-kappaB associated cytokines: TNF-alpha, IL-1alpha, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus.

Authors:  Nelson L Rhodus; Bin Cheng; Sandra Myers; Lindsay Miller; Vu Ho; Frank Ondrey
Journal:  Mol Carcinog       Date:  2005-10       Impact factor: 4.784

Review 2.  Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer.

Authors:  Robert L Ferris; Theresa L Whiteside; Soldano Ferrone
Journal:  Clin Cancer Res       Date:  2006-07-01       Impact factor: 12.531

3.  Characterization of the evolution of immune phenotype during the development and progression of squamous cell carcinoma of the head and neck.

Authors:  Anna-Maria A De Costa; Corinne A Schuyler; David D Walker; M Rita I Young
Journal:  Cancer Immunol Immunother       Date:  2011-11-25       Impact factor: 6.968

Review 4.  Protective mechanisms of head and neck squamous cell carcinomas from immune assault.

Authors:  M Rita I Young
Journal:  Head Neck       Date:  2006-05       Impact factor: 3.147

5.  HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.

Authors:  Takeshi Ogino; Hiroshi Shigyo; Hideyuki Ishii; Akihiro Katayama; Naoyuki Miyokawa; Yasuaki Harabuchi; Soldano Ferrone
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

Review 6.  Emerging mechanisms of immunosuppression in oral cancers.

Authors:  A Jewett; C Head; N A Cacalano
Journal:  J Dent Res       Date:  2006-12       Impact factor: 6.116

7.  Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma.

Authors:  Donald T Weed; Paolo Serafini; Jennifer L Vella; Isildinha M Reis; Adriana C De la Fuente; Carmen Gomez; Zoukaa Sargi; Ronen Nazarian; Joseph Califano; Ivan Borrello
Journal:  Clin Cancer Res       Date:  2014-10-15       Impact factor: 12.531

8.  Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production.

Authors:  C Walker; F Kristensen; F Bettens; A L deWeck
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

Review 9.  Smoking-related DNA and protein adducts in human tissues.

Authors:  David H Phillips
Journal:  Carcinogenesis       Date:  2002-12       Impact factor: 4.944

10.  Salivary levels of TNF-α and IL-6 in patients with oral premalignant and malignant lesions.

Authors:  M Juretić; R Cerović; M Belušić-Gobić; I Brekalo Pršo; L Kqiku; S Špalj; S Pezelj-Ribarić
Journal:  Folia Biol (Praha)       Date:  2013       Impact factor: 0.906

View more
  9 in total

1.  Epidermal growth factor receptor signaling in precancerous keratinocytes promotes neighboring head and neck cancer squamous cell carcinoma cancer stem cell-like properties and phosphoinositide 3-kinase inhibitor insensitivity.

Authors:  Khoa A Nguyen; Madison J Keith; Stephen B Keysar; Spencer C Hall; Anamol Bimali; Antonio Jimeno; Xiao-Jing Wang; Christian D Young
Journal:  Mol Carcinog       Date:  2022-04-13       Impact factor: 5.139

2.  Local Immune Responsiveness of Mice Bearing Premalignant Oral Lesions to PD-1 Antibody Treatment.

Authors:  Corinne A Levingston; M Rita I Young
Journal:  Cancers (Basel)       Date:  2017-06-02       Impact factor: 6.639

3.  Transient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD-1 antibodies.

Authors:  Corinne A Levingston; M Rita I Young
Journal:  Int J Cancer       Date:  2017-01-24       Impact factor: 7.396

Review 4.  Redirecting the focus of cancer immunotherapy to premalignant conditions.

Authors:  M Rita I Young
Journal:  Cancer Lett       Date:  2017-01-24       Impact factor: 8.679

5.  Immunological and classical subtypes of oral premalignant lesions.

Authors:  Jean-Philippe Foy; Chloé Bertolus; Sandra Ortiz-Cuaran; Marie-Alexandra Albaret; William N Williams; Wenhua Lang; Solène Destandau; Geneviève De Souza; Emilie Sohier; Janice Kielbassa; Emilie Thomas; Sophie Deneuve; Patrick Goudot; Alain Puisieux; Alain Viari; Li Mao; Christophe Caux; S M Lippman; P Saintigny
Journal:  Oncoimmunology       Date:  2018-09-21       Impact factor: 7.723

6.  Transcriptional analysis highlights three distinct immune profiles of high-risk oral epithelial dysplasia.

Authors:  Chai Phei Gan; Bernard Kok Bang Lee; Shin Hin Lau; Thomas George Kallarakkal; Zuraiza Mohamad Zaini; Bryan Kit Weng Lye; Rosnah Binti Zain; Hans Prakash Sathasivam; Joe Poh Sheng Yeong; Natalia Savelyeva; Gareth Thomas; Christian H Ottensmeier; Hany Ariffin; Sok Ching Cheong; Kue Peng Lim
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

Review 7.  Microenvironment in Oral Potentially Malignant Disorders: Multi-Dimensional Characteristics and Mechanisms of Carcinogenesis.

Authors:  Shuzhi Deng; Shimeng Wang; Xueke Shi; Hongmei Zhou
Journal:  Int J Mol Sci       Date:  2022-08-11       Impact factor: 6.208

Review 8.  Leukoplakia and Immunology: New Chemoprevention Landscapes?

Authors:  Roberto Grigolato; Maria Eleonora Bizzoca; Luca Calabrese; Stefania Leuci; Michele Davide Mignogna; Lorenzo Lo Muzio
Journal:  Int J Mol Sci       Date:  2020-09-19       Impact factor: 5.923

Review 9.  Microenvironmental modulation of the developing tumour: an immune-stromal dialogue.

Authors:  James O Jones; William M Moody; Jacqueline D Shields
Journal:  Mol Oncol       Date:  2020-08-28       Impact factor: 6.603

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.